ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637411 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637411; 2) Community: the network communities that were significantly associated with the response to NSC 637411; 3) Molecule: the relationships between components within communities and NSC 637411; 4) MDR: the compounds that were significantly associated with the NSC 637411.

NSC Compound Enrichment Correlation
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.022188614181866 0.19081953
NSC 726217 Combretastatin A4-analogue 0.022188614181866 0.065288112
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.022188614181866 0.16770463
NSC 743695 Null 0.022188614181866 0.12738184
NSC 753598 Null 0.022188614181866 0.046753832
NSC 762346 Null 0.022188614181866 0.14805218
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.022188614181866 0.16421592
NSC 92207 Null 0.022188614181866 0.16237921
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.0235234559682125 0.34258634
NSC 665883 Null 0.0235234559682125 0.089997831
Total:92  Current:48    [First] [Prev] [Next] [Last]